{"id":6361,"date":"2024-06-10T17:45:46","date_gmt":"2024-06-10T08:45:46","guid":{"rendered":"https:\/\/hd.lne.st\/?p=6361"},"modified":"2024-11-24T18:33:45","modified_gmt":"2024-11-24T09:33:45","slug":"molmir","status":"publish","type":"post","link":"https:\/\/avf.lne.st\/en\/2024\/06\/10\/molmir\/","title":{"rendered":"MOLMIL, a company that develops \"Molecule to Mill\" drug discovery platform technology, will participate in the AdVenture Forum!"},"content":{"rendered":"<p><span style=\"font-weight: 400\">which will be held in Osaka on Saturday, June 29, 2024.<a href=\"https:\/\/hd.lne.st\/forum\/202406osaka\/\">Ad Venture Forum in Osaka<\/a>to \"mill the molecule\" in the development of basic drug discovery technologies.<\/span><a href=\"https:\/\/www.molmir.co.jp\/\"><span style=\"font-weight: 400\">MOLMIL Corporation<\/span><\/a><span style=\"font-weight: 400\">will be participating in the event.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Ad Venture Forum is a career forum for young researchers, including master's, doctoral, and post-doctoral fellows, who conduct research at universities and graduate schools.<\/span><\/p>\n<p><a href=\"https:\/\/www.molmir.co.jp\/\"><span style=\"font-weight: 400\">MOLMIL Corporation<\/span><\/a><span style=\"font-weight: 400\">The company is also characterized by the participation of scientific advisors and co-researchers from more than 10 research institutes. The company aims to become an organization that does not limit itself to specific technologies or disease areas, but rather implements the seeds of various academia into society one after another.<\/span><\/p>\n<p><span style=\"font-weight: 400\">We are looking for enthusiastic people who want to participate in the forum, such as those who want to aim for a world without intractable diseases and disorders for which there is no cure, and those who are interested in the development of new drug discovery platform technologies and the social implementation of academia seeds. Students, graduate students, post-doctoral fellows, and others who wish to take on the challenge of world-changing research and development are invited to participate in the Adventure Forum.<\/span><\/p>\n<p><span style=\"font-weight: 400\">&lt;Participating companies<\/span><\/p>\n<p><span style=\"font-weight: 400\"><a href=\"https:\/\/www.molmir.co.jp\/\">MOLMIL Corporation<\/a>\u3000<\/span><\/p>\n<p><strong>Curing all kinds of diseases and energizing society<\/strong><\/p>\n<p><span style=\"font-weight: 400\">MOLMIR\" is a word coined from the word \"miru\", which means to look at a molecule. By capturing the movement of molecules at the atomic level, we will develop treatments for intractable diseases including ALS (amyotrophic lateral sclerosis) and present new possibilities for drug discovery from Japan to the world.<\/span><\/p>\n<p><b>Add Venture Forum Overview<\/b><\/p>\n<p><span style=\"font-weight: 400\">Ad Venture Forum is a place where young research personnel such as students and post-doctoral fellows and venture companies can meet under the theme of \"Discovering new opportunities for researchers\".<\/span><\/p>\n<p>\u3010\u3010<a href=\"https:\/\/hd.lne.st\/forum\/202406osaka\/\">Ad Venture Forum (June 2024\/Osaka)<\/a>]<\/p>\n<p><a href=\"https:\/\/hd.lne.st\/forum\/202406osaka\/\">https:\/\/hd.lne.st\/forum\/202406osaka\/<\/a><\/p>\n<p><span style=\"font-weight: 400\">\uff1cOverview\uff1e<\/span><\/p>\n<p><span style=\"font-weight: 400\">Date: Saturday, June 29, 2024, 13:00-17:30<\/span><\/p>\n<p><span style=\"font-weight: 400\">Place: Osaka Science &amp; Technology Center (1-8-4 Utsubohonmachi, Nishi-ku, Osaka City)<\/span><\/p>\n<p><span style=\"font-weight: 400\">Participants: 40 students, post-doctoral fellows and other young researchers<\/span><\/p>\n<p>Exhibitors: 9 companies<br \/>\nEAGLYS Corporation, INOCA Corporation, ACSL Corporation, Kenrobotech Corporation, Sydecas Corporation, FiberCraze Corporation, PITTAN Corporation, MOLMIL Corporation, Liverness Corporation<\/p>\n<p><span style=\"font-weight: 400\">\uff1cSchedule of the day\uff1e<\/span><\/p>\n<p><span style=\"font-weight: 400\">13:00-13:15 Opening Ceremony<\/span><\/p>\n<p><span style=\"font-weight: 400\">13:15-13:45 1min QP presentation by a venture company<\/span><\/p>\n<p><span style=\"font-weight: 400\">14:14-15:00 Booth Session 1<\/span><\/p>\n<p><span style=\"font-weight: 400\">15:00-15:45 Booth Session 2<\/span><\/p>\n<p><span style=\"font-weight: 400\">15:45-16:30 Booth Session 3<\/span><\/p>\n<p><span style=\"font-weight: 400\">16:45-17:30 Closing Ceremony and Networking<\/span><\/p>\n<p><span style=\"font-weight: 400\">\uff1cHow to participate\uff1e<\/span><\/p>\n<p><span style=\"font-weight: 400\">Pre-registration (free of charge) is required. After registering your Leave a Nest ID, please click the link below to register by filling out the required information.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Application form \u2192.<\/span><a href=\"https:\/\/id.lne.st\/project\/add_venture2024\/regist\/basic_info\/1\"><span style=\"font-weight: 400\">https:\/\/id.lne.st\/project\/add_venture2024\/regist\/basic_info\/1<\/span><\/a><\/p>\n<p><b>For inquiries regarding this matter, please contact<\/b><\/p>\n<p><span style=\"font-weight: 400\">Liberace Corporation Attn: Shigenaga<\/span><\/p>\n<p><a href=\"mailto:hd@Lnest.jp\"><span style=\"font-weight: 400\">hd@Lnest.jp<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Ltd., which is engaged in the development of \"Molecule to Mill\" drug discovery platform technology, will participate in the \"Ad Venture Forum in Osaka\" to be held on Saturday, June 29, 2024, in Osaka, Japan....<\/p>","protected":false},"author":9021,"featured_media":6877,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","footnotes":""},"categories":[8,4],"tags":[],"acf":[],"aioseo_notices":[],"modified_by":"\u85cf\u672c\u6589\u5e78","_links":{"self":[{"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/posts\/6361"}],"collection":[{"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/users\/9021"}],"replies":[{"embeddable":true,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/comments?post=6361"}],"version-history":[{"count":3,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/posts\/6361\/revisions"}],"predecessor-version":[{"id":7047,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/posts\/6361\/revisions\/7047"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/media\/6877"}],"wp:attachment":[{"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/media?parent=6361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/categories?post=6361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avf.lne.st\/en\/wp-json\/wp\/v2\/tags?post=6361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}